BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38576219)

  • 1. Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy.
    Xing H; Li X
    Chemistry; 2024 Jun; 30(32):e202400425. PubMed ID: 38576219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
    Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
    Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy.
    Bai Y; Wang Y; Zhang X; Fu J; Xing X; Wang C; Gao L; Liu Y; Shi L
    Int J Pharm; 2019 Oct; 570():118636. PubMed ID: 31446027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Nanoparticles to Reprogram the Tumor Immune Microenvironment for Improved Cancer Immunotherapy.
    Saeed M; Gao J; Shi Y; Lammers T; Yu H
    Theranostics; 2019; 9(26):7981-8000. PubMed ID: 31754376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy.
    Le QV; Suh J; Oh YK
    AAPS J; 2019 May; 21(4):64. PubMed ID: 31102154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
    Yang J; Zhang C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered nanomaterials for synergistic photo-immunotherapy.
    Guo R; Wang S; Zhao L; Zong Q; Li T; Ling G; Zhang P
    Biomaterials; 2022 Mar; 282():121425. PubMed ID: 35217344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
    Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomaterials for cancer immunotherapy.
    Song W; Musetti SN; Huang L
    Biomaterials; 2017 Dec; 148():16-30. PubMed ID: 28961532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
    Aikins ME; Xu C; Moon JJ
    Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle mediated cancer immunotherapy.
    Gupta J; Safdari HA; Hoque M
    Semin Cancer Biol; 2021 Feb; 69():307-324. PubMed ID: 32259643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles.
    Zhang M; Kim JA; Huang AY
    Front Immunol; 2018; 9():341. PubMed ID: 29535722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment.
    Rajendrakumar SK; Uthaman S; Cho CS; Park IK
    Biomacromolecules; 2018 Jun; 19(6):1869-1887. PubMed ID: 29677439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy.
    Xu T; Liu Z; Huang L; Jing J; Liu X
    Front Immunol; 2022; 13():1057850. PubMed ID: 36532066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
    Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
    Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy.
    Musetti S; Huang L
    ACS Nano; 2018 Dec; 12(12):11740-11755. PubMed ID: 30508378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors.
    Kosti P; Maher J; Arnold JN
    Front Immunol; 2018; 9():1104. PubMed ID: 29872437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy.
    Lu Q; Kou D; Lou S; Ashrafizadeh M; Aref AR; Canadas I; Tian Y; Niu X; Wang Y; Torabian P; Wang L; Sethi G; Tergaonkar V; Tay F; Yuan Z; Han P
    J Hematol Oncol; 2024 Apr; 17(1):16. PubMed ID: 38566199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating CD8
    Wang B; Zhou J; Li R; Tang D; Cao Z; Xu C; Xiao H
    Adv Mater; 2024 May; 36(21):e2311640. PubMed ID: 38341667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.